FDA approves first-ever eye drop that corrects age-related vision loss
By
Alicia Lasek
Nov 02, 2021
The new drug, Vuity, adjusts pupil size and corrects near vision without affecting distance vision, drugmaker Allergan says.
New program will test clinician awareness of drugs known to increase falls in dementia
Aug 23, 2022
The Stop-Falls-D program uses prompts to help reduce the use of drugs that affect the central nervous system, such as sleeping pills, anti-anxiety medications and pain relievers, in patients with dementia.
Diabetes deaths reach 100,000 second year in a row, sparking calls for federal action
By
Alicia Lasek
Feb 01, 2022
The news is cause for alarm, experts say. A congressional commission is calling for broad federal policy changes to tackle the swiftly growing problem.
Retail giants wrap up vaccine clinics, launch new LTC services for ongoing care
By
Alicia Lasek
Apr 23, 2021
CVS Health and Walgreens have completed their final LTC clinics, and are handing the reins to Omnicare and PharMerica to provide ongoing COVID-19 vaccination services in skilled nursing facilities and...
VA will not add Alzheimer’s drug Aduhelm to its formulary
By
Alicia Lasek
Aug 12, 2021
The Department of Veterans Affairs has chosen not to include aducanumab (Aduhelm) in its national list of covered drugs, citing risk of adverse events and lack of evidence of positive impact on cognition,...
COVID-19 antiviral drug trials expected to wrap up within months: report
By
Alicia Lasek
Sep 27, 2021
Clinical trials for new COVID-19 antiviral drugs are expected to wrap up by winter, sparking hopes that a daily pill to treat COVID-19 infection is closer to fruition, according to a new report.
Remdesivir cuts risk of severe COVID-19 by 87 percent in non-hospitalized patients
By
Alicia Lasek
Jan 21, 2022
The results suggest that remdesivir (brand name Veklury) could be used to treat outpatients early in the disease course, researchers say. The drug currently is authorized for use only in hospitalized COVID-19...
Diabetes drugs may have potential to slow Alzheimer’s progression, researchers say
May 09, 2023
Evidence is growing that GLP-1 agonists may be good candidates for testing against neurodegenerative disease.
C. difficile prevalence fell during pandemic, but treatment costs higher, study finds
By
Alicia Lasek
Aug 31, 2022
Unprecedented pandemic infection control measures may have helped reduce Clostridioides difficile infections in the United States, researchers report.
Brief training for LTC nurses leads to 6 months of reduced psychotropics use
By
Alicia Lasek
Oct 26, 2021
Wards with trained nurses showed a significant reduction in psychotropic drug use and drug costs. Maintenance strategies may be needed, however, as the improvements had waned by 12 months, researchers...